Rolph Timothy, Chief Scientific Officer of Akero Therapeutics ($AKRO), sold about $5.7 million worth of company shares across 23 open market transactions in the last 365 days, with the most recent on October 7, 2025. His total sales rank 1774th among nearly 12,000 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 389 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Common Stock | 238339 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.29% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Common Stock | 43810 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.05% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 3421 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 5032 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 2328 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 56579 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.07% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 119969 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.15% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 84051 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.10% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 26152 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.03% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 29074 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.04% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 29074 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.04% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | D | Stock Option (Right to Buy) | 49945 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.06% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 94268 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.11% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4739 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3527 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4284 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 43064 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.05% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2796 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 4739 | $21.10 | 282,149.0000 | 82,316,179 | 1.71% | 0.01% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 94268 | $0.62 | 277,410.0000 | 82,316,179 | 51.47% | 0.11% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 2796 | $0.62 | 183,142.0000 | 82,316,179 | 1.55% | 0.00% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 4284 | $21.09 | 180,346.0000 | 82,316,179 | 2.43% | 0.01% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 43064 | $6.36 | 176,062.0000 | 82,316,179 | 32.38% | 0.05% |
| Nov. 25, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 3527 | $28.35 | 132,998.0000 | 82,316,179 | 2.72% | 0.00% |
| Nov. 17, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | G | Common Stock | 37100 | $0.00 | 129,471.0000 | 82,316,179 | 22.27% | 0.05% |
| Oct. 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 12500 | $28.35 | 179,071.0000 | 79,620,128 | 7.50% | 0.02% |
| Oct. 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 49,945.0000 | 79,620,128 | 20.02% | 0.02% |
| Oct. 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 1037 | $46.82 | 166,571.0000 | 79,620,128 | 0.62% | 0.00% |
| Oct. 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 11463 | $46.01 | 167,608.0000 | 79,620,128 | 6.40% | 0.01% |
| Sept. 11, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 553 | $43.02 | 166,571.0000 | 79,620,128 | 0.33% | 0.00% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 7044 | $0.00 | 389.0000 | 79,620,128 | 94.77% | 0.01% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 295 | $0.00 | 62,445.0000 | 79,620,128 | 0.47% | 0.00% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 5161 | $0.00 | 0.0000 | 79,620,128 | 100.00% | 0.01% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 7044 | $21.09 | 174,168.0000 | 79,620,128 | 4.21% | 0.01% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 5161 | $6.36 | 179,329.0000 | 79,620,128 | 2.96% | 0.01% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 295 | $28.35 | 179,624.0000 | 79,620,128 | 0.16% | 0.00% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 12466 | $44.17 | 167,158.0000 | 79,620,128 | 6.94% | 0.02% |
| Sept. 8, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 34 | $44.88 | 167,124.0000 | 79,620,128 | 0.02% | 0.00% |
| Aug. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 12500 | $21.09 | 179,624.0000 | 79,620,128 | 7.48% | 0.02% |
| Aug. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 6962 | $49.49 | 167,124.0000 | 79,620,128 | 4.00% | 0.01% |
| Aug. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 7,433.0000 | 79,620,128 | 62.71% | 0.02% |
| Aug. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 5538 | $49.07 | 174,086.0000 | 79,620,128 | 3.08% | 0.01% |
| July 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 10634 | $50.93 | 168,990.0000 | 79,620,128 | 5.92% | 0.01% |
| July 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 1825 | $52.00 | 167,165.0000 | 79,620,128 | 1.08% | 0.00% |
| July 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 41 | $52.62 | 167,124.0000 | 79,620,128 | 0.02% | 0.00% |
| July 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 19,933.0000 | 79,620,128 | 38.54% | 0.02% |
| July 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 12500 | $21.09 | 179,624.0000 | 79,620,128 | 7.48% | 0.02% |
| June 30, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | A | Common Stock | 890 | $23.87 | 167,124.0000 | 79,620,128 | 0.54% | 0.00% |
| June 18, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 1129 | $54.84 | 166,234.0000 | 79,620,128 | 0.67% | 0.00% |
| June 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 2358 | $54.00 | 167,363.0000 | 79,620,128 | 1.39% | 0.00% |
| June 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 9350 | $53.37 | 172,871.0000 | 79,620,128 | 5.13% | 0.01% |
| June 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 12500 | $21.10 | 182,221.0000 | 79,620,128 | 7.37% | 0.02% |
| June 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 3150 | $53.84 | 169,721.0000 | 79,620,128 | 1.82% | 0.00% |
| June 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 24611 | $21.09 | 194,332.0000 | 79,620,128 | 14.50% | 0.03% |
| June 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 389 | $21.10 | 194,721.0000 | 79,620,128 | 0.20% | 0.00% |
| June 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 25000 | $55.04 | 169,721.0000 | 79,620,128 | 12.84% | 0.03% |
| June 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 389.0000 | 79,620,128 | 96.98% | 0.02% |
| June 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 389 | $0.00 | 0.0000 | 79,620,128 | 100.00% | 0.00% |
| June 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 24611 | $0.00 | 32,433.0000 | 79,620,128 | 43.14% | 0.03% |
| May 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 12,889.0000 | 79,620,128 | 49.23% | 0.02% |
| May 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 12500 | $21.10 | 182,221.0000 | 79,620,128 | 7.37% | 0.02% |
| May 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 3550 | $42.26 | 178,671.0000 | 79,620,128 | 1.95% | 0.00% |
| May 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 8650 | $43.87 | 170,021.0000 | 79,620,128 | 4.84% | 0.01% |
| May 6, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 300 | $44.50 | 169,721.0000 | 79,620,128 | 0.18% | 0.00% |
| April 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2566 | $0.00 | 26,152.0000 | 79,620,128 | 8.94% | 0.00% |
| April 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 6250 | $21.10 | 175,971.0000 | 79,620,128 | 3.68% | 0.01% |
| April 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 6250 | $41.03 | 169,721.0000 | 79,620,128 | 3.55% | 0.01% |
| April 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3684 | $0.00 | 25,389.0000 | 79,620,128 | 12.67% | 0.00% |
| April 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 6250 | $0.00 | 28,718.0000 | 79,620,128 | 17.87% | 0.01% |
| April 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 6250 | $21.10 | 175,971.0000 | 79,620,128 | 3.68% | 0.01% |
| April 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 2200 | $35.36 | 173,771.0000 | 79,620,128 | 1.25% | 0.00% |
| April 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 3750 | $36.05 | 170,021.0000 | 79,620,128 | 2.16% | 0.00% |
| April 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 100 | $36.93 | 169,921.0000 | 79,620,128 | 0.06% | 0.00% |
| April 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 200 | $37.92 | 169,721.0000 | 79,620,128 | 0.12% | 0.00% |
| March 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 516 | $44.88 | 169,721.0000 | 79,620,128 | 0.30% | 0.00% |
| March 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 3162 | $44.90 | 170,237.0000 | 79,620,128 | 1.82% | 0.00% |
| March 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 12500 | $21.10 | 182,737.0000 | 79,620,128 | 7.34% | 0.02% |
| March 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 9338 | $44.40 | 173,399.0000 | 79,620,128 | 5.11% | 0.01% |
| March 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 34,968.0000 | 79,620,128 | 26.33% | 0.02% |
| Feb. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 5903 | $56.92 | 170,237.0000 | 0 | 3.35% | 0.00% |
| Feb. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 18750 | $0.00 | 47,468.0000 | 0 | 28.32% | 0.00% |
| Feb. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 12847 | $56.33 | 176,140.0000 | 0 | 6.80% | 0.00% |
| Feb. 5, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 18750 | $21.10 | 188,987.0000 | 0 | 11.01% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 16264 | $0.00 | 66,218.0000 | 0 | 19.72% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 16264 | $21.10 | 201,487.0000 | 0 | 8.78% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 14986 | $19.87 | 185,223.0000 | 0 | 8.80% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 13812 | $54.76 | 187,675.0000 | 0 | 6.86% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 5059 | $55.62 | 182,616.0000 | 0 | 2.70% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 12379 | $56.97 | 170,237.0000 | 0 | 6.78% | 0.00% |
| Jan. 27, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 14986 | $0.00 | 119,969.0000 | 0 | 11.10% | 0.00% |
| Jan. 7, 2025 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | G | Common Stock | 14000 | $0.00 | 170,237.0000 | 0 | 7.60% | 0.00% |
| Dec. 26, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | G | Common Stock | 14100 | $0.00 | 184,237.0000 | 0 | 7.11% | 0.00% |
| Dec. 17, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 3800 | $0.00 | 134,955.0000 | 0 | 2.74% | 0.00% |
| Dec. 17, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 3800 | $19.87 | 182,137.0000 | 0 | 2.13% | 0.00% |
| Dec. 17, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 3800 | $31.10 | 178,337.0000 | 0 | 2.09% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | A | Common Stock | 20000 | $0.00 | 198,337.0000 | 0 | 11.21% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Common Stock | 2450 | $19.87 | 180,787.0000 | 0 | 1.37% | 0.00% |
| Dec. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 2450 | $31.03 | 178,337.0000 | 0 | 1.36% | 0.00% |
| Dec. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 2368 | $30.79 | 178,337.0000 | 0 | 1.31% | 0.00% |
| Dec. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | M | Stock Option (Right to Buy) | 2450 | $0.00 | 138,755.0000 | 0 | 1.74% | 0.00% |
| Sept. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 537 | $26.18 | 180,705.0000 | 0 | 0.30% | 0.00% |
| June 28, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | A | Common Stock | 1064 | $19.94 | 181,242.0000 | 0 | 0.59% | 0.00% |
| June 11, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 2380 | $22.64 | 180,178.0000 | 0 | 1.30% | 0.00% |
| March 13, 2024 | Akero Therapeutics, Inc. | $AKRO | Rolph Timothy | Chief Scientific Officer | S | Common Stock | 619 | $28.33 | 182,558.0000 | 0 | 0.34% | 0.00% |